Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry-Reference-Cited by-同舟云学术

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

Published:1998-11 Issue:11 Volume:4 Page:1302-1307
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kilby J. Michael,Hopkins Sam,Venetta Thomas M.,DiMassimo Betty,Cloud Gretchen A.,Lee Jeannette Y.,Alldredge Leslie,Hunter Eric,Lambert Dennis,Bolognesi Dani,Matthews Thomas,Johnson M. Ross,Nowak Martin A.,Shaw George M.,Saag Michael S.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1198_1302.pdf

Reference49 articles.

1. Carpenter, C.C. et al. Anti-retroviral therapy for HIV infection in 1998. J. Am. Med. Assoc. 280, 78–86 (1998).

2. Eron, J.J. et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. N. Engl. J. Med. 333, 1662–9 ( 1995).

3. Markowitz, M. et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N. Engl. J. Med. 333, 1534–9 (1995).

4. Hammer, S. et al. A randomized, placebo-controlled trial of indinavir in combination with two nucleoside analogs in HIV-infected persons with CD4 cell counts less than or equal to 200 per cubic millimeter. N. Engl. J. Med. 337, 725 (1997).

5. Saag, M.S. Nucleoside analogs: adverse effects. Hosp. Pract. 27 (supp), 26-36 (1992).

Cited by 947 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Chimeric Antibody against the HIV-1 Fusion Inhibitory Peptide MT-C34 with a High Affinity and Fc-Mediated Cellular Cytotoxicity;Biology;2024-08-29

2. Establishment of an at-line nanofractionation-based screening platform by coupling HPLC-MS/MS with high-throughput fluorescence polarization bioassay for natural SARS-CoV-2 fusion inhibitors;Journal of Chromatography A;2024-08

3. Investigating vulnerability of the conserved SARS-CoV-2 spike's heptad repeat 2 as target for fusion inhibitors using chimeric miniproteins;International Journal of Biological Macromolecules;2024-03

4. Recent Developments and Future Perspectives of Purine Derivatives as a Promising Scaffold in Drug Discovery;Current Topics in Medicinal Chemistry;2024-03

5. Antiviral Protein–Protein Interaction Inhibitors;Journal of Medicinal Chemistry;2024-02-23